{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Alan Palkowitz, PhD","description":" In the first episode of&amp;nbsp;Life Science Lab,&amp;nbsp;host Ari Landon, PhD sits down with Alan&amp;nbsp;Palkowitz,&amp;nbsp;PhD,&amp;nbsp;President and CEO of the Indiana Biosciences Research Institute (IBRI), to discuss how the IBRI is accelerating translational&amp;nbsp;research and advancing new therapies through collaboration across the life sciences ecosystem. They explore what makes the&amp;nbsp;IBRI model unique, the institute\u2019s scientific priorities, and what it takes to move discoveries toward real-world impact.&amp;nbsp;&amp;nbsp;   &amp;nbsp; &amp;nbsp; About the Indiana Biosciences Research Institute  The Indiana Biosciences Research Institute (IBRI) is a first-in-class translational medicine institute dedicated to advancing life sciences in the race to&amp;nbsp;eliminate&amp;nbsp;disease and improve human health and life. By connecting early-stage biotech companies with&amp;nbsp;cutting-edge&amp;nbsp;life science discoveries \u2014and backed by the mission and resources of industry leaders, investors, and philanthropic partners\u2014 IBRI is successfully evolving a new, independent model to conquer disease, uniting&amp;nbsp;previously fragmented forces in the quest for cures.&amp;nbsp;   Learn more about the IBRI here:&amp;nbsp;https:\/\/www.indianabiosciences.org\/&amp;nbsp;   ","author_name":"Life Science Lab","author_url":"https:\/\/sites.libsyn.com\/605565","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/39827655\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/197765510"}